Document is current
Any future updates will be listed below
-
Authors
Gkotsis, Dimosthenis E.
Raiter, Yaron
Thompson, David
Peillon, Aurelie
Hao, Jing
Schwarz, Adam J.
- License Information
-
More Information
Article History
Received: 1 December 2025
Accepted: 25 March 2026
First Online: 6 April 2026
Declarations
:
: All authors are currently full-time employees of GE HealthCare, a manufacturer and distributor of Rapiscan (active ingredient: regadenoson) in Europe. No other competing interests such as: financial interests, funding, or non-financial interests are present, other than employment.
